Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03250767 · ClinicalTrials.gov registry record
Clinical Evaluation of the Integra® Titan™ Modular Shoulder System Generation 2.5 for Primary Shoulder Joint Replacement
A clinical trial, sponsored by Smith & Nephew.
- Terminated
- Registry status
- 58
- Enrollment target
NCT03250767 is a clinical trial that was terminated before completion, run by Smith & Nephew. The registered enrollment target is 58 participants.
The verdict
NCT03250767 was terminated before completion, sponsored by Smith & Nephew.
- TERMINATED
- Registry status
- 58 participants
- Enrollment target
Study Summary
A post market, prospective, non-randomized, multi-center, open-label, clinical study using survivorship as the reference performance goal to study the safety and efficacy of the Titan Modular Shoulder System 2.5 when used for primary shoulder arthroplasty.
Interventions
- DEVICE Integra Titan Modular Shoulder System 2.5
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2017-08-01 |
| Est. Completion | 2023-03-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03250767
The ClinicalTrials.gov registry entry for NCT03250767 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Smith & Nephew, which has 72 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Integra Titan Modular Shoulder System 2.5 is the first listed.
NCT03250767 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03250767 about?
NCT03250767 is a clinical study titled "Clinical Evaluation of the Integra® Titan™ Modular Shoulder System Generation 2.5 for Primary Shoulder Joint Replacement". A post market, prospective, non-randomized, multi-center, open-label, clinical study using survivorship as the reference performance goal to study the safety and efficacy of the Titan Modular Shoulder System 2.5 when used for primary shoulder arthroplasty.
What is the current status of trial NCT03250767?
This trial is currently terminated. The enrollment target is 58 participants. The study started on 2017-08-01. Estimated completion is 2023-03-10.
What interventions are being tested in trial NCT03250767?
The interventions under investigation include: Integra Titan Modular Shoulder System 2.5 (DEVICE).
Who is sponsoring clinical trial NCT03250767?
This trial is sponsored by Smith & Nephew, which has 72 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.